ADPT | Adaptive Biotechnologies CorporationNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$25.80
+$0.74 (+2.95%)

Adaptive Biotechnologies Corporation (ADPT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $25.80 vs 50 $26.37 / 200 $19.68
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 Jul 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $26.64 vs 50 $19.06 / 200 $10.07
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 8 Sep 2025 ยท projected 21 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $25.80 vs 50 $26.32 / 200 $24.24
Projection
No cross projected
Test
No active test
Last cross
Golden cross 15 Jun 2026 ยท projected 28 bars out

Cross history

12
crosses on record since 2020
7 golden5 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Jul 2026Golden moderatedaily21 bars outNot tested
15 Jun 2026Golden4-hour28 bars outNot tested
16 Apr 2026Death moderatedaily27 bars out5 bar cross test
3 Mar 2026Death4-hour18 bars out2 bar cross test
week of 8 Sep 2025Golden steepweekly21 bars outNot tested

About ADPT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$47M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.